Behavioral and physiological components of type 1 diabetes and its management can contribute to worsened sleep and health outcomes, which can vary by age, according to Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado.
Adolescents with type 1 diabetes (T1D) who don't get enough sleep are at higher risk for more severe cardiometabolic risk factors, said Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado, at SLEEP 2022.
Transcript
What short-term and long-term effects can T1D have on a person’s sleep?
Individuals with type 1 diabetes are at increased risk for sleep disturbance. That could be due to both behavioral and physiological aspects of both diabetes itself and its management. For example, they may be woken up in the night and need to treat their low or high blood sugars, their glucose monitors may alarm in the night, waking them up and causing extra disruption. So it can definitely have an impact that way.
How do these effects change based on the patient’s age?
The research that we did looked at sleep and health outcomes in both adolescents and adults with type 1 diabetes. What we found was that, for adolescents who got less than 7 hours of sleep per night, they had some greater cardiometabolic risk factors, so higher BMI, worse insulin sensitivity, things of that nature. But we didn't see that same relationship for the adult population.
We know that adolescence is a really critical period in terms of both overall health and development as well as for sleep, so there's so much growth and development going on. But then also, with regards to sleep, we know that adolescents tend overall just to get insufficient sleep. They're often going to bed really late, but have to wake up very early in the morning for school. It seems like it's definitely something really important to do further research on in patients, particularly with type 1 diabetes.
Are there also inversed effects, where sleep can affect T1D?
It's a really interesting question and something that we're hoping to answer in future research. We're really interested to know if sleep might impact blood sugars or glycemic control the next day.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More